Roche confident in Alzheimer's programmes, despite Lilly flop

ZURICH, Nov 23 (Reuters) - Roche said on Wednesday

it still believed drugs targeting a protein called beta amyloid

had potential to help fight Alzheimer's disease, despite the

high-profile failure of such a product from Eli Lilly.

Read more